Français
ItalianoBond Gilead Sciences 4.4% ( US375558AU71 ) in USD
| Issuer | Gilead Sciences | ||||||||||||||||||||||||||||||||||||||
| Market price | 102.46 % ▲ | ||||||||||||||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||||||||||||||
| ISIN code |
 US375558AU71 ( in USD )
|
||||||||||||||||||||||||||||||||||||||
| Interest rate | 4.4% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||||||||||
| Maturity | 30/11/2021 - Bond has expired | ||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||||||||||
| Total amount | 1 250 000 000 USD | ||||||||||||||||||||||||||||||||||||||
| Cusip | 375558AU7 | ||||||||||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AU71, pays a coupon of 4.4% per year. The coupons are paid 2 times per year and the Bond maturity is 30/11/2021 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AU71, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AU71, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||
